Resultado de búsqueda
Hace 13 horas · Press photo Boehringer's biopharmaceutical production in Biberach, Germany Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today announced a strong acceleration of its pipeline in 2023, as pivotal trials in key research ...
